SLN:NASDAQ
Silence Therapeutics PLC - ADR
$12.50
arrow_upward
+0.32%(+0.040) 1D
$12.45
arrow_downward
-0.40% (-0.050)bedtimeAfter hours
Closed: Sep 16, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SLN...
Open
$12.53
High
$12.78
Low
$12.24
Mkt. cap
752.62M
Avg. vol.
1.56M
Volume
983.81K
52-wk high
$17.58
52-wk low
$4.19
EPS
-$1.45
Beta
1.45
Shares outstanding
60.21M
No. of employees
88
Open
$12.53
High
$12.78
Low
$12.24
Mkt. cap
752.62M
Avg. vol.
1.56M
Volume
983.81K
52-wk high
$17.58
52-wk low
$4.19
EPS
-$1.45
Beta
1.45
Shares outstanding
60.21M
No. of employees
88
News stories
From web sources and news partners
Investing.com
·
9 hours ago
Silence Therapeutics at Morgan Stanley conference: divesiran drives focus
Investing.com
·
1 day ago
Silence Therapeutics at H.C. Wainwright conference: divesiran drives focus
Profile
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London. Wikipedia
About Silence Therapeutics PLC - ADR
CEOCraig A Tooman
Employees88
Founded1994
Headquarters-
SectorBiotechnology
Websitesilence-therapeutics.com